Everything You Need to Know About Cardiac output determinants for Step 1

Cardiac output (CO) questions are everywhere on Step 1 because they let test writers connect hemodynamics → organ perfusion → symptoms → treatments in one neat package. If you can predict how preload, afterload, contractility, and heart rate change CO—and how the body compensates—you’ll crush not only physiology questions but also shock, heart failure, murmurs, and drug mechanism stems.

---

The one-line definition (and why it matters)

Cardiac output is the volume of blood the heart pumps per minute:

$CO = HR \times SV$

• HR = heart rate (beats/min)
• SV = stroke volume (mL/beat)

Normal resting adult CO is about 5 L/min (varies with size and physiologic state).

Why Step cares: CO is the “upstream” determinant of blood pressure and tissue perfusion:

• $MAP \approx CO \times SVR$
  (More precisely: $MAP = CO \times SVR + CVP$, but CVP is usually small.)

First Aid cross-ref (approx):

• Cardiovascular Physiology → Hemodynamics (CO, MAP, SVR)
• Heart failure, shock states, autonomic drugs affecting hemodynamics

---

Stroke volume: the big three determinants

Stroke volume is primarily determined by:

1. Preload (ventricular end-diastolic volume/pressure)
2. Afterload (pressure the ventricle must overcome to eject)
3. Contractility (inotropy; intrinsic myocardial performance)

A useful identity: $SV = EDV - ESV$

Where:

• EDV increases with preload
• ESV increases with afterload and decreases with contractility

---

Preload: “How full is the ventricle before it squeezes?”

Definition (testable phrasing)

Preload ≈ LV end-diastolic volume (EDV) (or ED pressure), largely determined by venous return.

Core mechanism: Frank–Starling law

• Increased preload → increased sarcomere stretch → increased force of contraction (up to a point) → increased SV
• On a Starling curve, preload changes move you along the same curve (contractility unchanged).

What increases preload?

High-yield causes:

• IV fluids
• Venoconstriction (e.g., sympathetic tone, $\alpha_1$ activation)
• Leg raise
• Pregnancy (increased plasma volume)
• Valve regurgitation (e.g., MR increases LV volume load)

What decreases preload?

• Hemorrhage/dehydration
• Venodilation (e.g., nitrates)
• Diuretics
• Positive pressure ventilation (decreases venous return)
• Tamponade/tension pneumothorax (obstructive shock physiology)

Pathophysiology tie-in: preload overload and failure

In systolic heart failure, the ventricle can be “stuck” on a flatter portion of the Starling curve:

• Increasing preload may not meaningfully increase CO
• Instead, it increases pulmonary congestion (dyspnea, orthopnea, crackles)

Clinical presentation clues

• Low preload: orthostasis, cool extremities (if low CO), flat neck veins
• High preload/volume overload: JVD, edema, pulmonary crackles

Diagnosis pearls

• Preload surrogates: JVP/CVP, IVC size/collapsibility (ultrasound), PCWP (Swan-Ganz)
• PCWP approximates left atrial pressure (and LV preload) in most settings

Treatment: preload manipulation (classic Step pharmacology)

• Decreasing preload: nitrates (venodilation), diuretics
• Increasing preload: IV fluids, blood products, venoconstrictors (context-dependent)

First Aid cross-ref:

• Drugs: nitrates, diuretics; shock; heart failure hemodynamics

---

Afterload: “How hard is it to push blood out?”

Definition

Afterload ≈ aortic pressure (MAP) / systemic vascular resistance (SVR) (for the LV). It’s the “pressure wall” the ventricle must overcome to eject.

Key relationship

• Increased afterload → increased ESV → decreased SV → decreased CO (unless compensated)

What increases afterload?

• Chronic HTN
• Aortic stenosis
• Vasoconstrictors (e.g., phenylephrine, high sympathetic tone)
• Hypothermia (vasoconstriction)

What decreases afterload?

• ACE inhibitors/ARBs
• Hydralazine
• Dihydropyridine CCBs
• Sepsis/anaphylaxis (pathologic vasodilation)

Clinical presentation clues

• High afterload states: can worsen HFrEF, cause S4 (stiff ventricle), exertional symptoms
• Aortic stenosis: syncope, angina, dyspnea with harsh systolic murmur radiating to carotids

Diagnosis pearls

• Hemodynamics (Swan-Ganz): high SVR in cardiogenic/hypovolemic shock; low SVR in distributive shock
• Echo: LV hypertrophy in chronic high afterload; valve gradients in AS

Treatment logic

• Reduce afterload to increase forward flow (especially in HFrEF):
  • ACEi/ARB/ARNI, hydralazine (plus nitrates in select patients)
• In acute hypotension, raising afterload may be temporarily necessary (pressor support)—but it can worsen CO in poor pump function.

First Aid cross-ref:

• Antihypertensives, shock types, valvular disease

---

Contractility (inotropy): “How strong is the squeeze at a given preload?”

Definition

Contractility is the intrinsic ability of cardiac myocytes to generate force independent of preload and afterload.

What increases contractility?

• $\beta_1$ stimulation (epinephrine, dobutamine)
• Increased intracellular Ca$^{2+}$
• Digoxin (inhibits Na/K ATPase → ↑ intracellular Na$^+$ → ↓ NCX → ↑ Ca$^{2+}$)

What decreases contractility?

• Ischemia/MI
• Acidosis
• $\beta$-blockers (acute effect)
• Non-DHP CCBs (verapamil/diltiazem)
• Cardiomyopathies (dilated)

Starling curve tie-in (super testable)

• Increased contractility shifts the Starling curve up/left (higher SV at same preload)
• Decreased contractility shifts it down/right

Clinical presentation clues

Low contractility → low CO symptoms:

• Fatigue, exercise intolerance
• Cool clammy skin, narrow pulse pressure (in severe low-flow states)
• Pulmonary edema if left-sided failure

Diagnosis

• Echo: reduced EF in HFrEF
• Biomarkers: troponin in acute ischemia; BNP in HF (context)

Treatment

• Chronic HFrEF: mortality benefit with neurohormonal blockade (not “inotropes” long-term)
  • ACEi/ARB/ARNI, evidence-based beta-blockers, MRA (spironolactone/eplerenone), SGLT2 inhibitors
• Acute decompensated low-output HF/cardiogenic shock: inotropes (e.g., dobutamine) + reperfusion if MI

First Aid cross-ref:

• Heart failure pharmacology; sympathetic pharmacology; digoxin

---

Heart rate: “The multiplier… with a catch”

Relationship with CO

$CO = HR \times SV$

• Increasing HR increases CO up to a point
• Too high HR reduces diastolic filling time → decreases preload/SV → CO can fall

Classic board concept: tachyarrhythmias can cause hypotension because the ventricle never fills.

What changes HR?

• Autonomics: sympathetic increases HR; parasympathetic decreases
• Drugs: $\beta$-agonists ↑ HR; $\beta$-blockers ↓ HR; anticholinergics ↑ HR
• Fever, anemia, hypovolemia (compensatory tachycardia)

Clinical tie-in: brady vs tachy symptoms

• Bradycardia: dizziness, syncope, hypotension
• Tachycardia: palpitations, chest pain (in CAD), lightheadedness

First Aid cross-ref:

• Arrhythmias, autonomic pharmacology

---

Put it together: a Step-style hemodynamics table

---

High-yield graph/curve associations (what they’re really asking)

Pressure–volume (PV) loop associations

You don’t need to draw perfect loops—just know what moves.

• Increased preload → increased EDV → loop widens (SV ↑)
• Increased afterload → increased ESV, higher systolic pressure → loop becomes taller/narrower (SV ↓)
• Increased contractility → decreased ESV → loop widens (SV ↑), steeper ESPVR line
• Decreased contractility (HFrEF) → increased ESV, lower SV; ESPVR slope decreases

First Aid cross-ref:

• Cardiac PV loops / ventricular function curves

---

Clinical syndromes tied to CO determinants (rapid-review)

Heart failure: HFrEF vs HFpEF (Step-relevant hemodynamics)

• HFrEF (systolic dysfunction): ↓ contractility → ↓ EF, ↑ ESV, compensatory ↑ preload → pulmonary congestion
• HFpEF (diastolic dysfunction): impaired relaxation/compliance → filling problems (preload “can’t translate” to EDV well), often S4, preserved EF but symptoms of congestion

Common etiologies:

• HFrEF: ischemic heart disease, dilated cardiomyopathy
• HFpEF: long-standing HTN (LVH), aging, restrictive processes

Shock states: link SVR + CO patterns

• Cardiogenic: ↓ CO, ↑ SVR, ↑ filling pressures
• Hypovolemic: ↓ CO, ↑ SVR, ↓ filling pressures
• Obstructive: ↓ CO, ↑ SVR, variable filling pressures (often ↑ JVP)
• Distributive (septic/anaphylactic/neurogenic): ↓ SVR; CO often ↑ early in sepsis

Board move: identify shock type by warm vs cold extremities, JVP, and SVR direction.

---

Diagnostic approach: how exam stems “measure” CO without saying CO

You’ll infer CO from:

• Pulse pressure (rough SV surrogate): narrow PP suggests low SV/CO; wide PP suggests high SV or low diastolic pressure (e.g., AR)
• Skin temperature: warm = low SVR; cool = high SVR/low flow
• Urine output: low perfusion → oliguria
• Mental status: hypoperfusion → confusion
• Lactate: global hypoperfusion (esp shock)

Tools:

• Echo: EF, valve disease, volume status clues
• Swan-Ganz: CO, SVR, PCWP (more Step 1 physiology than Step 2 management nowadays, but still tested)

---

Treatment principles: choose the lever that fixes the problem

Think in levers:

• Too little preload? Give fluids/blood (unless cardiogenic overload)
• Too much preload (congestion)? Diuretics, venodilators
• Too much afterload? Vasodilate (ACEi, hydralazine)
• Too little contractility (pump failure)? Inotropes acutely; guideline-directed medical therapy chronically
• HR too fast/too slow? Fix rhythm/rate, consider underlying cause (hypoxia, fever, drugs)

Step trap: reflexes

• Vasodilators ↓ MAP → reflex tachycardia
• $\alpha_1$ agonists ↑ SVR → reflex bradycardia
• Nitrates mainly venodilate → big preload drop, less wall stress → helps angina

---

High-yield associations & “classic” exam one-liners

• Preload reducers: nitrates, diuretics, venodilation, positive pressure ventilation
• Afterload reducers: ACEi/ARB, hydralazine, DHP CCBs
• Inotropes: dobutamine (β1), digoxin (↑ Ca$^{2+}$)
• CO vs MAP: low CO can still have normal MAP early if SVR rises (compensation)
• Tachycardia can lower CO by reducing diastolic filling time
• HFrEF Starling curve shifts down/right; inotropes shift it up/left
• Septic shock early: low SVR + high CO (“warm shock”) → bounding pulses, warm skin; later CO can fall

---

Quick self-check (mini practice prompts)

1. A patient with acute hemorrhage: what happens to preload, HR, SVR, CO?
2. Phenylephrine infusion: what happens to afterload and HR? Why?
3. Aortic stenosis primarily affects which determinant of SV?
4. Dobutamine in cardiogenic shock: which determinant does it target first?

(If you want, send your answers and I’ll grade them like a Step explanation.)